Company
nikangtx
Established in 2017, NiKang Therapeutics® is a clinical-stage biotech company dedicated to developing innovative small molecule drugs.
Also known as NiKang Therapeutics, NiKang Therapeutics, Inc.
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Founded
- 2017
- Legal name
- NiKang Therapeutics, Inc.
Claim, correct or request removal
Record updated 28 September 2026
About
NiKang Therapeutics is a clinical stage biotech company focused on discovering and developing innovative small molecule oncology medicines to help patients with unmet medical needs.
Funding snapshot
- Total raised
- $250MSum of rounds, as of 2026-09-17Source (opens in a new tab)
- Latest round
- Series C, $200M2021-05-26
Funding rounds
- Series C
- $200M2021-05-31, Announced
- Series C
- $200M2021-05-26, Company stated
- Round, 2021
- $200M2021-05-20, SEC form D sold, 30 investors
- Series B
- $50M2020-09-14, Company stated
Products
- Web
- NKT2152
- Web
- NKT3964
- Web
- NKT5097
Loading relationship preview